HealthEquity, Inc. (HQY) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 33.77 means the share price is 33.77 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $7.84B is the value of all shares combined. Beta 0.26: the stock has moved about 74% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerHealthEquity, Inc. (HQY) trades at $93.81 with MoonshotScore 90/100 (Grade A+). HealthEquity, Inc. provides technology-enabled services platforms and solutions for managing health savings accounts (HSAs) and related consumer-directed benefits. Market cap: $7.84B, Sector: Healthcare.
Price as of Sep 10, 2026 · Last analyzed: May 9, 2026HQY stock analysis for 2026: Analysts have set a consensus price target of $115.33 for HealthEquity, Inc., suggesting 22.9% upside from the current price of $93.81. The AI MoonshotScore is 90/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.
HQY: 1/3 scored disciplines lean bullish. Dominant signal: Ken Griffin bullish.
How is this calculated? →Strongest side: Growth Durability (10/10, Strong). Weakest side: Valuation (6/10, Neutral).
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
HealthEquity, Inc. (HQY) Healthcare & Pipeline Overview
HealthEquity, Inc. delivers cloud-based platforms for health savings accounts (HSAs) and consumer-directed benefits, enabling users to manage healthcare spending, savings, and investment decisions. With a focus on technology-driven solutions, HealthEquity serves employers, health plans, and individuals across the United States, positioning itself in the growing healthcare information services sector.
What Is the Investment Thesis for HQY?
HealthEquity, Inc. presents a notable research candidate within the healthcare information services sector. The company's strong market position in health savings accounts (HSAs) and its technology-driven platform offer significant growth potential. With a P/E ratio of 33.77 and a profit margin of 16.4%, HealthEquity demonstrates solid financial performance. Key growth catalysts include the increasing adoption of HSAs, expansion of its service offerings, and strategic partnerships with health plans and employers. The company's beta of 0.26 indicates lower volatility compared to the broader market. However, potential risks include regulatory changes in the healthcare industry and increasing competition. HealthEquity's ability to maintain its competitive advantage and capitalize on market trends will be crucial for sustained growth and value creation.
Based on FMP financials and quantitative analysis
HQY Key Highlights
Market capitalization of $7.84B, reflecting investor confidence in HealthEquity's growth prospects.
- P/E ratio of 33.77, indicating a premium valuation based on earnings.
- Profit margin of 16.4%, demonstrating efficient operations and profitability.
- Gross margin of 69.5%, showcasing the company's ability to maintain pricing power and manage costs effectively.
- Beta of 0.26, suggesting lower volatility compared to the overall market, potentially appealing to risk-averse investors.
Who Are HQY's Competitors?
HQY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| GMED Globus Medical, Inc. | $74.52 | -0.69% | $10.1B | 955-pillar |
| PEN Penumbra, Inc. | $318.73 | -0.26% | $12.6B | 945-pillar |
| DVA DaVita Inc. | $181.33 | -0.92% | $11.6B | 745-pillar |
| MOH Molina Healthcare, Inc. | $200.28 | +3.17% | $10.5B | 715-pillar |
| BTSG BrightSpring Health Services, Inc. | $57.88 | -6.63% | $11.4B | 695-pillar |
| TXG 10x Genomics, Inc. | $66.38 | -1.35% | $8.43B | 395-pillar |
| MTHRY M3, Inc. | $5.40 | +2.86% | $7.20B | 519-signal |
| HNGE Hinge Health, Inc. | $90.08 | -1.35% | $6.97B | 905-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are HQY's Key Strengths?
Strong market position in health savings accounts (HSAs).
- Technology-driven platform with comprehensive service offerings.
- Scalable business model with high gross margins.
- Established network of partners and distribution channels.
What Are HQY's Weaknesses?
Dependence on regulatory environment and healthcare policies.
- Exposure to interest rate fluctuations.
- Potential for cybersecurity breaches and data privacy concerns.
- Limited international presence.
What Could Drive HQY Stock Higher?
Increasing adoption of health savings accounts (HSAs) by employers and individuals.
- Expansion of HealthEquity's service offerings and platform capabilities.
- Potential regulatory changes that could further incentivize HSA adoption.
- Strategic partnerships with health plans and benefits administrators.
What Are the Key Risks for HQY?
Rich valuation — a P/E of 33.77 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.
- Insider selling — insiders were net sellers of roughly $4.2M recently.
- Regulatory changes that could negatively impact the HSA market.
- Increased competition from other healthcare benefits administrators.
- Economic downturn that could reduce healthcare spending.
- Cybersecurity threats and data breaches.
What Are the Growth Opportunities for HQY?
- Expansion of HSA Market: The increasing adoption of Health Savings Accounts (HSAs) presents a significant growth opportunity for HealthEquity. As healthcare costs rise, more employers and individuals are turning to HSAs as a cost-effective way to manage their healthcare expenses. HealthEquity can capitalize on this trend by expanding its HSA offerings, targeting new customer segments, and enhancing its platform functionality. The HSA market is projected to continue growing at a double-digit rate over the next five years, providing a substantial runway for HealthEquity's growth.
- Strategic Partnerships: Forming strategic partnerships with health plans, benefits administrators, and other healthcare providers can drive significant growth for HealthEquity. These partnerships can expand the company's reach, increase its customer base, and enhance its service offerings. By integrating its platform with other healthcare systems, HealthEquity can streamline the healthcare process and improve the overall customer experience. These partnerships can also provide access to new markets and customer segments, further accelerating growth.
- Product Innovation: Investing in product innovation and expanding its service offerings can drive growth for HealthEquity. By developing new features and functionalities for its platform, the company can attract new customers and retain existing ones. This includes expanding its investment options, enhancing its mobile app, and offering personalized financial planning tools. Continuous innovation will be crucial for maintaining a competitive advantage and capturing market share. The company can also explore new areas such as telehealth and digital health solutions.
- Acquisitions: Strategic acquisitions can accelerate HealthEquity's growth and expand its market presence. By acquiring complementary businesses, the company can gain access to new technologies, customer segments, and geographic markets. Acquisitions can also help HealthEquity consolidate the market and reduce competition. The company should focus on acquiring companies that align with its strategic goals and can be integrated seamlessly into its existing operations. This can provide synergies and improve overall efficiency.
- Data Analytics: Leveraging data analytics to improve its services and personalize the customer experience presents a significant growth opportunity for HealthEquity. By analyzing customer data, the company can identify trends, predict future healthcare needs, and offer customized solutions. This can improve customer satisfaction, increase retention rates, and drive revenue growth. HealthEquity can also use data analytics to optimize its operations, reduce costs, and improve efficiency. Investing in data analytics capabilities will be crucial for maintaining a competitive advantage and delivering superior value to customers.
What Are HQY's Competitive Advantages?
- Network Effect: As more employers and individuals adopt HealthEquity's platform, the value of the platform increases for all users.
- Switching Costs: The complexity of managing healthcare benefits and the integration of HealthEquity's platform with other systems create high switching costs for customers.
- Scalability: HealthEquity's cloud-based platform allows it to scale its operations efficiently and cost-effectively.
- Data Advantage: The company's access to a large amount of healthcare data provides it with a competitive advantage in terms of personalization and service optimization.
What Does HQY Do?
HealthEquity, Inc., founded in 2002 and headquartered in Draper, Utah, provides technology-enabled service platforms that empower consumers and employers to make informed healthcare decisions. The company's core offering revolves around cloud-based platforms designed to facilitate health savings and spending decisions. These platforms enable users to pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices through health savings accounts (HSAs). HealthEquity also offers a mutual fund investment platform and an online-only automated investment advisory service called Advisor. Beyond HSAs, HealthEquity provides flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation services. The company also administers pre-tax commuter benefit programs. HealthEquity serves its clients through a direct sales force, benefits brokers and advisors, and a network of health plans, benefits administrators, benefits brokers, consultants, and retirement plan record-keepers. HealthEquity's integrated platform and comprehensive service offerings position it as a key player in the healthcare information services industry, catering to the increasing demand for consumer-directed healthcare solutions.
What Products and Services Does HQY Offer?
- Provides cloud-based platforms for managing health savings accounts (HSAs).
- Offers tools for paying healthcare bills and comparing treatment options.
- Delivers personalized benefit and clinical information to users.
- Administers flexible spending accounts (FSAs) and health reimbursement arrangements (HRAs).
- Manages Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation services.
- Administers pre-tax commuter benefit programs.
- Offers a mutual fund investment platform for HSA holders.
- Provides online automated investment advisory services through Advisor.
How Does HQY Make Money?
- Generates revenue from fees associated with managing health savings accounts (HSAs).
- Earns interchange revenue from debit card transactions made through its platform.
- Receives administrative fees for managing flexible spending accounts (FSAs) and health reimbursement arrangements (HRAs).
- Collects fees for providing COBRA continuation services and pre-tax commuter benefit programs.
What Industry Does HQY Operate In?
HealthEquity operates within the healthcare information services industry, which is experiencing significant growth due to increasing demand for consumer-directed healthcare solutions. The market is driven by rising healthcare costs, regulatory changes, and the growing popularity of health savings accounts (HSAs). The competitive landscape includes companies like GMED: Globus Medical, Inc. and PEN: Penumbra, Inc., as well as other healthcare benefits administrators and technology providers. HealthEquity's focus on technology-enabled platforms and comprehensive service offerings positions it to capitalize on these trends and gain market share.
Who Are HQY's Key Customers?
- Employers who offer HSAs and other benefits to their employees.
- Health plans that partner with HealthEquity to provide HSA solutions to their members.
- Individuals who use HealthEquity's platform to manage their healthcare spending and savings.
- Benefits brokers and advisors who recommend HealthEquity's services to their clients.
Research confidence
Broad, current evidence sits behind this analysis.
- ● Scored on 100% of our measures
- ● Price is current
- ● Latest filing 15 days ago
- ● Covered by analysts
Why 90?
Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.
What is helping
- +0.60 Financial-health checklist (Financial Strength)
- +0.42 Gross profit per dollar of assets (Business Quality)
- +0.40 Return on equity (Business Quality)
What is holding it back
- -0.40 Debt to equity (Financial Strength)
- -0.12 Net debt vs earnings (Financial Strength)
- -0.07 Enterprise value vs EBITDA (Valuation)
Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 90 |
| 2026-08-26 | 90 |
| 2026-08-29 | 96 |
| 2026-09-01 | 95 |
| 2026-09-04 | 89 |
| 2026-09-07 | 90 |
| 2026-09-10 | 90 |
What changed?
The score has stayed at 90.
What moved it up or down:
- -12 Valuation
- +9 Financial Strength
- -8 Momentum
Over the same 18 days the stock moved -11.0%.
Company Profile
HealthEquity, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Draper, US. The company is led by CEO Scott R. Cutler. HQY has traded publicly since 2014.
Key Financial Metrics
Return on equity for HealthEquity, Inc. stands at 10.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.0%, showing how much profit it generates from its asset base. HQY trades at a trailing price-to-earnings ratio of 33.77, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 5.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.44 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.6%, the inverse of the P/E and a quick read on earnings relative to price.
HQY Valuation & Market Position
With a $7.84B market cap, HealthEquity, Inc. sits in the mid-cap segment of the market. Analyst price targets span from $105.00 to $142.00, with a consensus of $115.33. At the current price of $93.81, that implies approximately 23% upside potential. Relative to its peer group, HQY's quantitative score of 90/100 is above the peer average of 73/100.
Quarterly Financial Performance: HealthEquity, Inc.
Revenue for HealthEquity, Inc. came in at $350.7M during Q2 FY2027, a 1.1% contraction versus the preceding quarter. The company recorded net income of $65.6M, with diluted EPS of $0.78. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, HQY averaged $0.69 in diluted EPS.
Financial Health
HealthEquity, Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.57 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
HealthEquity, Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 9.7% above estimates on average.
Insider Activity
Over the past six months, HealthEquity, Inc. insiders filed 28 SEC Form 4 transactions — 18 sales and 10 purchases. On net that is roughly 22K shares disposed (about $4.2M), a signal worth weighing alongside the fundamentals.
HQY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Strong market position in health savings accounts (HSAs).
- Technology-driven platform with comprehensive service offerings.
- Scalable business model with high gross margins.
- Established network of partners and distribution channels.
Bear Case
- Dependence on regulatory environment and healthcare policies.
- Exposure to interest rate fluctuations.
- Potential for cybersecurity breaches and data privacy concerns.
- Limited international presence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2027 | $351M | $66M | $0.78 |
| Q1 FY2027 | $355M | $69M | $0.82 |
| Q4 FY2026 | $335M | $50M | $0.57 |
| Q3 FY2026 | $322M | $52M | $0.59 |
Q2 FY2027 · filed 27 Aug 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
HQY Latest News
-
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
zacks.com · Sep 4, 2026
-
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
zacks.com · Sep 2, 2026
-
Here's Why HealthEquity (HQY) is a Strong Growth Stock
zacks.com · Sep 2, 2026
-
HealthEquity’s (HQY) Health Savings Engine Hits A New Gear
Yahoo! Finance: HQY News · Sep 1, 2026
HQY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HQY.
Price Targets
Median: $111.00 (+22.9% from current price)
Source: FMP analyst consensus · as of Sep 1, 2026 · an estimate, not advice
HQY MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. HQY scores 90/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Latest News
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
Here's Why HealthEquity (HQY) is a Strong Growth Stock
HealthEquity’s (HQY) Health Savings Engine Hits A New Gear
Leadership: Scott R. Cutler
CEO
Scott R. Cutler serves as the CEO of HealthEquity, bringing extensive experience in the financial and technology sectors. Prior to joining HealthEquity, Cutler held leadership positions at various companies, including executive roles at the New York Stock Exchange (NYSE) and Intercontinental Exchange (ICE). His background includes expertise in market operations, technology strategy, and financial management. Cutler's experience positions him to lead HealthEquity in its mission to simplify healthcare savings and spending.
Track Record: Since assuming the role of CEO, Scott Cutler has focused on driving growth and innovation at HealthEquity. Key achievements under his leadership include expanding the company's market share in the HSA space, enhancing its technology platform, and forging strategic partnerships. Cutler has also emphasized a customer-centric approach, aiming to improve the overall user experience and drive customer satisfaction. His leadership has contributed to HealthEquity's continued success and growth in the healthcare information services industry.
HQY Healthcare Stock FAQ
What does the AI Score mean for HQY?
HQY holds an AI Score of 90/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. HealthEquity, Inc. provides technology-enabled services platforms and solutions for managing health savings accounts (HSAs) and related consumer-directed benefits.
Is HQY a good stock?
Stock Expert AI does not rate HQY buy, sell or hold. HealthEquity, Inc. carries a MoonshotScore of 90/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for HQY?
HealthEquity, Inc. faces several risks inherent to the healthcare information services industry. Regulatory changes, particularly those affecting health savings accounts (HSAs), pose a significant threat. Increased competition from established players and new entrants could erode market share. Economic downturns may lead to reduced healthcare spending and lower HSA contributions.
What are the key factors to evaluate for HQY?
HealthEquity, Inc. (HQY) holds an AI score of 90/100 (high). P/E: 33.77x vs the S&P 500's ~20-25x. Analysts target $115.33 (+23%). Not financial advice.
How frequently does HQY data refresh on this page?
HQY's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven HQY's recent stock price performance?
HealthEquity, Inc. (HQY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong market position in health savings accounts (HSAs). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HQY overvalued or undervalued right now?
HealthEquity, Inc. (HQY) trades at 33.77x earnings. Analysts target $115.33 (+23%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of HQY?
Yes, most major brokerages offer fractional shares of HealthEquity, Inc. (HQY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track HQY's earnings and financial reports?
HealthEquity, Inc. (HQY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for HQY earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest reporting period.